Factors Correlated with Success Rate of Outpatient Smoking Cessation Services in Taiwan

Wei-Hsin Huang, Hsin-Yin Hsu, Betty Chia-Chen Chang, Fong-Ching Chang, Wei-Hsin Huang, Hsin-Yin Hsu, Betty Chia-Chen Chang, Fong-Ching Chang

Abstract

Smoking is the leading cause of preventable death. The purpose of this study was to explore the patient’s and physician’s factors that are correlated with smoking cessation success rate. A total of 877 smokers who visited the outpatient smoking cessation services at a medical center in Northern Taiwan were recruited for the study. Phone interviews were carried out six months after the initial visit to evaluate the success rate of smoking cessation. The result showed that the abstinence rate at six-month was 37.7%. By the multivariate logistic regression model, the predictive factors of abstinence were smokers who had a lower Fagerström test for cigarette dependence (FTCD), lower exhaled carbon monoxide (CO) concentration, or who smoked less than 20 cigarettes per day at the first visit. Smokers who had more than one smoking cessation outpatient visit or seen by physicians who, on average, delivered more than one smoking cessation consultations per week also led to a higher success rate. Therefore, we suggest that physicians should put more efforts and encourage follow-up visits for some smokers by knowing their characteristics at the first visit. Furthermore, physicians with more experience in smoking cessation consultation seemed to be more likely to help patients to quit smoking successfully.

Keywords: outpatient smoking cessation service; smoking cessation; success rate.

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Health Promotion Administration Taiwan Tobacco Control Annual Report. [(accessed on 5 April 2018)];2016 Available online: .
    1. Fagerstrom K. Determinants of tobacco use and renaming the FTND to the Fagerstrom Test for Cigarette Dependence. Nicotine Tob. Res. 2012;14:75–78. doi: 10.1093/ntr/ntr137.
    1. World Health Organization (WHO) Tobacco Free Initiative (TFI) 2018. WHO; Geneva, Switzerland: 2018. [(accessed on 28 May 2018)]. Available online:
    1. Chang F.C., Hu T.W., Lin M., Yu P.T., Chao K.Y. Effects of financing smoking cessation outpatient services in Taiwan. Tob. Control. 2008;17:183–189. doi: 10.1136/tc.2007.021907.
    1. Curry S.J., Grothaus L.C., McAfee T., Pabiniak C. Use and cost effectiveness of smoking-cessation services under four insurance plans in a health maintenance organization. N. Engl. J. Med. 1998;339:673–679. doi: 10.1056/NEJM199809033391006.
    1. Kaper J., Wagena E.J., Willemsen M.C., Van Schayck C.P. Reimbursement for smoking cessation treatment may double the abstinence rate: Results of a randomized trial. Addiction. 2005;100:1012–1020. doi: 10.1111/j.1360-0443.2005.01097.x.
    1. Heatherton T.F., Kozlowski L.T., Frecker R.C., Fagerstrom K.O. The Fagerstrom Test for Nicotine Dependence: A revision of the Fagerstrom Tolerance Questionnaire. Br. J. Addict. 1991;86:1119–1127. doi: 10.1111/j.1360-0443.1991.tb01879.x.
    1. Caponnetto P., Polosa R. Common predictors of smoking cessation in clinical practice. Respir. Med. 2008;102:1182–1192. doi: 10.1016/j.rmed.2008.02.017.
    1. Hsueh K.C., Chen C.Y., Yang Y.H., Huang C.L. Smoking cessation program in outpatient clinics of Family Medicine Department in Taiwan: A longitudinal evaluation. Eval. Health Prof. 2010;33:12–25. doi: 10.1177/0163278709356185.
    1. Ho K.S., Choi B.W., Chan H.C., Ching K.W. Evaluation of biological, psychosocial, and interventional predictors for success of a smoking cessation programme in Hong Kong. Hong Kong Med. J. 2016;22:158–164. doi: 10.12809/hkmj154549.
    1. Kottke T.E., Battista R.N., DeFriese G.H., Brekke M.L. Attributes of successful smoking cessation interventions in medical practice. A meta-analysis of 39 controlled trials. JAMA. 1988;259:2883–2889. doi: 10.1001/jama.259.19.2883.
    1. Chang F.C., Hu T.W., Lo S.Y., Yu P.T., Chao K.Y., Hsiao M.L. Quit smoking advice from health professionals in Taiwan: The role of funding policy and smoker socioeconomic status. Tob. Control. 2010;19:44–49. doi: 10.1136/tc.2009.031435.
    1. Li L., Borland R., Yong H.H., Fong G.T., Bansal-Travers M., Quah A.C., Sirirassamee B., Omar M., Zanna M.P., Fotuhi O. Predictors of smoking cessation among adult smokers in Malaysia and Thailand: Findings from the International Tobacco Control Southeast Asia Survey. Nicotine Tob. Res. 2010;12(Suppl. 1):S34–S44. doi: 10.1093/ntr/ntq030.
    1. Abdullah A.S., Driezen P., Quah A.C., Nargis N., Fong G.T. Predictors of smoking cessation behavior among Bangladeshi adults: Findings from ITC Bangladesh survey. Tob. Induc. Dis. 2015;13:23. doi: 10.1186/s12971-015-0050-y.
    1. Messer K., Trinidad D.R., Al-Delaimy W.K., Pierce J.P. Smoking cessation rates in the United States: A comparison of young adult and older smokers. Am. J. Public Health. 2008;98:317–322. doi: 10.2105/AJPH.2007.112060.
    1. Smith P.H., Bessette A.J., Weinberger A.H., Sheffer C.E., McKee S.A. Sex/gender differences in smoking cessation: A review. Prev. Med. 2016;92:135–140. doi: 10.1016/j.ypmed.2016.07.013.
    1. Wu P.C., Hsueh K.C., Mar G.Y., Hsueh S.C., Tu M.S., McRobbie H., Hajek P. Gender differences in outcome of an attempt to stop smoking among smokers attending a smoking cessation clinic in Taiwan: 3-year follow-up study. Eval. Health Prof. 2016;39:317–325. doi: 10.1177/0163278715616439.
    1. Perkins K.A., Levine M.D., Marcus M.D., Shiffman S. Addressing women’s concerns about weight gain due to smoking cessation. J. Subst. Abuse Treat. 1997;14:173–182. doi: 10.1016/S0740-5472(96)00158-4.
    1. Dale L.C., Glover E.D., Sachs D.P., Schroeder D.R., Offord K.P., Croghan I.T., Hurt R.D. Bupropion for smoking cessation: Predictors of successful outcome. Chest. 2001;119:1357–1364. doi: 10.1378/chest.119.5.1357.
    1. Breslau N., Johnson E.O. Predicting smoking cessation and major depression in nicotine-dependent smokers. Am. J. Public Health. 2000;90:1122–1127.
    1. Monso E., Campbell J., Tønnesen P., Gustavsson G., Morera J. Sociodemographic predictors of success in smoking intervention. Tob. Control. 2001;10:165–169. doi: 10.1136/tc.10.2.165.
    1. Goldstein A.O., Gans S.P., Ripley-Moffitt C., Kotsen C., Bars M. Use of expired air carbon monoxide testing in clinical tobacco treatment settings. Chest. 2018;153:554–562. doi: 10.1016/j.chest.2017.11.002.
    1. Van Eerd E.A., Risør M.B., Spigt M., Godycki-Cwirko M., Andreeva E., Francis N., Wollny A., Melbye H., Van Schayck O., Kotz D. Why do physicians lack engagement with smoking cessation treatment in their COPD patients? A multinational qualitative study. NPJ Prim. Care Respir. Med. 2017;27:41. doi: 10.1038/s41533-017-0038-6.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera